ALK+ LBCL is a type of rare CD20-negative invasive non-Hodgkin lymphoma (4), accounting for less than 1% of diffuse large B-cell lymphoma (DLBCL) cases. This evidence concerns the gene ALK and diffuse large B-cell lymphoma.